This article is more than 5 years old. Information may no longer be current.
New compliance device for glaucoma patients unveiled
SAN FRANCISCO — A device that helps ophthalmologists and patients measure glaucoma medication compliance is now available for users of Travatan, said Ronald L. Gross, MD, here at an evening symposium held in conjunction with the American Society of Cataract and Refractive Surgery meeting.
According to Dr. Gross, patients put their Travatan (travoprost, Alcon) drops into a holder that can automatically tell how many drops are dispensed, and at what intervals. When the patient returns to the office, the physician can easily monitor compliance.
Dr. Gross said the device is Food and Drug Administration approved and is available at no cost to physicians.
“Right now, 95% of the patients are reporting positive experiences with the Travatan Dosing Aid, and 85% of the physicians are happy with it as well,” he said.
Dr. Gross described the device during an Alcon-sponsored symposium on “Innovations in Ophthalmology.”